Literature DB >> 28726018

Association of Vagotomy and Decreased Risk of Subsequent Ischemic Stroke in Complicated Peptic Ulcer Patients: an Asian Population Study.

Chu-Wen Fang1, Chun-Hung Tseng2,3, Shih-Chi Wu4,5, William Tzu-Liang Chen2,6, Chih-Hsin Muo7.   

Abstract

OBJECTIVES: The primary management of peptic ulcers is medical treatment. Persistent exacerbation of a peptic ulcer may lead to complications (perforation and/or bleeding). There has been a trend toward the use of a less invasive surgical simple suture, simple local suture or non-operative (endoscopic/angiography) hemostasis rather than acid-reducing vagotomy (i.e., vagus nerve severance) for treating complicated peptic ulcers. Other studies have shown the relationship between high vagus nerve activity and survival in cancer patients via reduced levels of inflammation, indicating the essential role of the vagus nerve. We were interested in the role of the vagus nerve and attempted to assess the long-term systemic effects after vagus nerve severance. Complicated peptic ulcer patients who underwent truncal vagotomy may represent an appropriate study population for investigating the association between vagus nerve severance and long-term effects. Therefore, we assessed the risks of subsequent ischemic stroke using different treatment methods in complicated peptic ulcer patients who underwent simple suture/hemostasis or truncal vagotomy/pyloroplasty.
METHODS: We selected 299,742 peptic ulcer patients without a history of stroke and Helicobacter pylori infection and an additional 299,742 matched controls without ulcer, stroke, and Helicobacter pylori infection from the National Health Insurance database. The controls were frequency matched for age, gender, Charlson comorbidity index (CCI) score, hypertension, hyperlipidemia history, and index year. Then, we measured the incidence of overall ischemic stroke in the two cohorts. The hazard ratio (HR) and the 95% confidence intervals (CIs) were estimated by Cox proportional hazard regression.
RESULTS: Compared to the controls, peptic ulcer patients had a 1.86-fold higher risk of ischemic stroke. There were similar results in gender, age, CCI, hypertension, and hyperlipidemia stratified analyses. In complicated peptic ulcer patients, those who received truncal vagotomy and pyloroplasty had a lower risk of ischemic stroke than patients who received simple suture/hemostasis (HR = 0.70, 95% CI = 0.60-0.81).
CONCLUSIONS: Our findings suggest that patients with peptic ulcers have an elevated risk of subsequent ischemic stroke. Moreover, there were associations between vagotomy and a decreased risk of subsequent ischemic stroke in complicated peptic ulcer patients.

Entities:  

Mesh:

Year:  2017        PMID: 28726018     DOI: 10.1007/s00268-017-4127-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  53 in total

Review 1.  Stroke and the immune system: from pathophysiology to new therapeutic strategies.

Authors:  Richard Macrez; Carine Ali; Olivier Toutirais; Brigitte Le Mauff; Gilles Defer; Ulrich Dirnagl; Denis Vivien
Journal:  Lancet Neurol       Date:  2011-05       Impact factor: 44.182

2.  Are genetic influences on peptic ulcer dependent or independent of genetic influences for Helicobacter pylori infection?

Authors:  H M Malaty; D Y Graham; I Isaksson; L Engstrand; N L Pedersen
Journal:  Arch Intern Med       Date:  2000-01-10

3.  Perforated peptic ulcer in a child with a vagus nerve stimulator for seizure control.

Authors:  Zachary D Van Wagoner; David C Evans; Johanna R Askegard-Giesmann; Brian D Kenney
Journal:  Brain Stimul       Date:  2013-05-21       Impact factor: 8.955

4.  Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).

Authors:  Gerhard Treiber; Joachim Wittig; Susanne Ammon; Siegfried Walker; Leen-Jan van Doorn; Ulrich Klotz
Journal:  Arch Intern Med       Date:  2002-01-28

5.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

Authors:  Yuqing Huo; Andreas Schober; S Bradley Forlow; David F Smith; Matthew Craig Hyman; Steffen Jung; Dan R Littman; Christian Weber; Klaus Ley
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

Review 6.  The very model of a modern etiology: a biopsychosocial view of peptic ulcer.

Authors:  S Levenstein
Journal:  Psychosom Med       Date:  2000 Mar-Apr       Impact factor: 4.312

7.  Increased risk of ischaemic stroke amongst patients with chronic osteomyelitis: a population-based cohort study in Taiwan.

Authors:  C-H Tseng; J-H Chen; C-H Muo; Y-J Chang; F-C Sung; C Y Hsu
Journal:  Eur J Neurol       Date:  2014-03-06       Impact factor: 6.089

8.  Vagal hyperactivity in stress induced gastric ulceration in rats.

Authors:  C H Cho; B S Qui; I C Bruce
Journal:  J Gastroenterol Hepatol       Date:  1996-02       Impact factor: 4.029

Review 9.  Evaluating periodontal risk for patients at risk of or suffering from atherosclerosis: recent biological hypotheses and therapeutic consequences.

Authors:  Olivier Huck; Kenza Saadi-Thiers; Henri Tenenbaum; Jean-Luc Davideau; Christine Romagna; Yves Laurent; Yves Cottin; José G Roul
Journal:  Arch Cardiovasc Dis       Date:  2011-05-11       Impact factor: 2.340

Review 10.  Reflex control of immunity.

Authors:  Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

View more
  2 in total

1.  Increased risk of subsequent benign prostatic hyperplasia in non-Helicobacter pylori-infected peptic ulcer patients: a population-based cohort study.

Authors:  Chu-Wen Fang; Chun-Hao Chen; Kun-Hung Shen; Wen-Chi Yang; Chih-Hsin Muo; Shih-Chi Wu
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

2.  Decreased risk of liver and intrahepatic cancer in non-H. pylori-infected perforated peptic ulcer patients with truncal vagotomy: a nationwide study.

Authors:  Shih-Chi Wu; Han-Tsung Cheng; Yu-Chun Wang; Chia-Wei Tzeng; Chia-Hao Hsu; Chih-Hsin Muo
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.